blood-brain barrier
Increased understanding of brain LSD pathology
progressive brain alteration
development of novel brain treatments
relevant brain metabolites
clinical LSD trials
brains of LSD patients
functional deficits
functional hallmarks of Lysosomal Storage Diseases
distinct extents of morphological brain abnormalities
Gaucher disease
Fabry disease
GD type
MPS type
relevance of MR measures
Parkinson’s disease
psychological deficits
Reproducible MR methods
various levels of cognitive deficits
age-related neurodegenerative diseases
effects of novel treatments
gene therapies
Neuro-metabolic
metabolic processes
cutting-edge accelerated proton MR spectroscopic imaging methodology
Excessive intracellular accumulation of lysosomal substances
search of optimal therapies
combination
significant damage
high-resolution T1
chaperones
markers
intrathecal enzyme administration
advanced diffusion MRI
T2-weighted ratio
triggers multi-organ
pseudo-continuous arterial spin labeling technique
atrophy
glycocerebroside
common features
perivascular spaces
prognostic magnetic resonance
glycosaminoglycans
mucopolysaccharidosis
globotriaosylceramide
need
Alzheimer’s
Medical University of Vienna
central nervous system
leukodystrophy
protocol